SHISEIDO WHITE LUCENT description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

SHISEIDO WHITE LUCENT

SHISEIDO AMERICA INC.

SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL BASE UV


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredient

Purpose

ACTIVE INGREDIENTS: Purpose
OCTINOXATE 2.9% Sunscreen
TITANIUM DIOXIDE 8.4% Sunscreen

Use

  • helps prevent sunburn

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

  • apply liberally 15 minutes before sun exposure
  • use a water resistant sunscreen if swimming or sweating
  • reapply at least every 2 hours
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
    • limit time in the sun, especially from 10 a.m. – 2 p.m.
    • wear long-sleeve shirts, pants, hats, and sunglasses
  • children under 6 months: Ask a doctor

Inactive Ingredients

CYCLOMETHICONE, WATER, SD ALCOHOL 40-B, BUTYLENE GLYCOL, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, PEG-10 DIMETHICONE, CETYL ETHYLHEXANOATE, TRANEXAMIC ACID, ALUMINUM HYDROXIDE, GLYCERIN, SORBITAN SESQUIISOSTEARATE, DISTEARDIMONIUM HECTORITE, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, PEG/PPG-14/7 DIMETHYL ETHER, 2-O-ETHYL ASCORBIC ACID, SODIUM HYALURONATE, STEARIC ACID, ISOSTEARIC ACID, ALUMINUM DISTEARATE, TRISODIUM EDTA, POLYSILICONE-2, SODIUM METABISULFITE, BHT, TOCOPHEROL, PHENOXYETHANOL, FRAGRANCE, TITANIUM DIOXIDE, IRON OXIDES, CHROMIUM HYDROXIDE GREEN,

SHISEIDO WHITE LUCENT Other information

  • protect this product in this container from excessive heat and direct sun.

Questions or comments?

Call toll free 1-800-906-7503

SHISEIDO AMERICA INC.
NEW YORK, N.Y. 10022
SHISEIDO DIST. NEW YORK • PARIS • MILANO

PRINCIPAL DISPLAY PANEL - 30mL Tube Carton - IVORY

SHISEIDO

WHITE LUCENT

Brightening
Spot-Control
Base UV

BROAD SPECTRUM
SPF 37

SUNSCREEN

30mL NET WT. 1.1 OZ.

SHISEIDO WHITE LUCENT

PRINCIPAL DISPLAY PANEL - 30mL Tube Carton - GREEN

SHISEIDO

WHITE LUCENT

Brightening
Spot-Control
Base UV

BROAD SPECTRUM
SPF 37

SUNSCREEN

30mL NET WT. 1.1 OZ.

SHISEIDO WHITE LUCENT

PRINCIPAL DISPLAY PANEL - 30mL Tube Carton - PINK

SHISEIDO

WHITE LUCENT

Brightening
Spot-Control
Base UV

BROAD SPECTRUM
SPF 37

SUNSCREEN

30mL NET WT. 1.1 OZ.

SHISEIDO WHITE LUCENT

SHISEIDO WHITE LUCENT

OCTINOXATE and TITANIUM DIOXIDE PASTE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:52686-249
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.9396 g
titanium dioxide 2.7216 g

Inactive Ingredients

Ingredient Name Strength
cyclomethicone
water
titanium dioxide
BUTYLENE GLYCOL
PEG-10 DIMETHICONE (600 CST)
CETYL ETHYLHEXANOATE
TRANEXAMIC ACID
aluminum hydroxide
GLYCERIN
STEARIC ACID
ferric oxide red
FERRIC OXIDE YELLOW
isostearic acid
PHENOXYETHANOL
ALUMINUM DISTEARATE
EDETATE TRISODIUM
2-O-ETHYL ASCORBIC ACID
SODIUM METABISULFITE
BUTYLATED HYDROXYTOLUENE
HYALURONATE SODIUM
.ALPHA.-TOCOPHEROL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 32.4 in 1 TUBE
2 NDC:52686-249-60 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-02-01


SHISEIDO WHITE LUCENT

OCTINOXATE and TITANIUM DIOXIDE PASTE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:52686-250
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.9396 g
titanium dioxide 2.7216 g

Inactive Ingredients

Ingredient Name Strength
cyclomethicone
water
titanium dioxide
BUTYLENE GLYCOL
PEG-10 DIMETHICONE (600 CST)
CETYL ETHYLHEXANOATE
TRANEXAMIC ACID
aluminum hydroxide
GLYCERIN
STEARIC ACID
ferric oxide red
FERRIC OXIDE YELLOW
isostearic acid
PHENOXYETHANOL
ALUMINUM DISTEARATE
EDETATE TRISODIUM
2-O-ETHYL ASCORBIC ACID
SODIUM METABISULFITE
BUTYLATED HYDROXYTOLUENE
HYALURONATE SODIUM
.ALPHA.-TOCOPHEROL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 32.4 in 1 TUBE
2 NDC:52686-250-60 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-02-01


SHISEIDO WHITE LUCENT

OCTINOXATE and TITANIUM DIOXIDE PASTE

Product Information

Product Type Human otc drug label Item Code (Source) NDC:52686-251
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.9396 g
titanium dioxide 2.7216 g

Inactive Ingredients

Ingredient Name Strength
cyclomethicone
water
titanium dioxide
BUTYLENE GLYCOL
PEG-10 DIMETHICONE (600 CST)
CETYL ETHYLHEXANOATE
TRANEXAMIC ACID
aluminum hydroxide
GLYCERIN
STEARIC ACID
ferric oxide red
FERRIC OXIDE YELLOW
isostearic acid
PHENOXYETHANOL
ALUMINUM DISTEARATE
EDETATE TRISODIUM
2-O-ETHYL ASCORBIC ACID
SODIUM METABISULFITE
BUTYLATED HYDROXYTOLUENE
HYALURONATE SODIUM
.ALPHA.-TOCOPHEROL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 32.4 in 1 TUBE
2 NDC:52686-251-60 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-02-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.